SAR445419
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR445419, covering 2025-09-12 to 2025-09-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]